Pierre Deltenre
Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030
Bruggmann P, Stoeckle M, Semela D, Schmid P, Razavi H, Rauch A, Mullhaupt B, Lavanchy D, Kouyos R, Fehr J, Deltenre P, Blach S, Negro F. Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030. Swiss Med Wkly 2017; 147:w14543.
09.11.2017Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030
09.11.2017Swiss Med Wkly 2017; 147:w14543
Bruggmann Philip, Stoeckle Marcel, Semela David, Schmid Patrick, Razavi Homie, Rauch Andri, Mullhaupt Beat, Lavanchy Daniel, Kouyos Roger, Fehr Jan, Deltenre Pierre, Blach Sarah, Negro Franco
Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis
De Gottardi A, Nery F, Deltenre P, Turon F, Engelmann C, Arya R, Caca K, Peck-Radosavljevic M, Leebeek F, Valla D, Garcia-Pagan J, Navascuès C, Mullhaupt B, Puente A, Trebicka J, Klinger C, Plessier A, Seijo S, Terziroli B, Magenta L, Semela D, Buscarini E, Langlet P, Görtzen J. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis. Liver Int 2016
25.10.2016Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis
25.10.2016Liver Int 2016
De Gottardi Andrea, Nery Filipe, Deltenre Pierre, Turon Fanny, Engelmann Cornelius, Arya Rupen, Caca Karel, Peck-Radosavljevic Markus, Leebeek Frank W G, Valla Dominique, Garcia-Pagan Juan Carlos, Navascuès Carmen, Mullhaupt Beat, Puente Angela, Trebicka Jonel, Klinger Christoph, Plessier Aurélie, Seijo Susana, Terziroli Benedetta, Magenta Lorenzo, Semela David, Buscarini Elisabetta, Langlet Philippe, Görtzen Jan